Desferal Injection, Powder, For Solution
Product Images NDC 87081-467

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Desferal (NDC 87081-467). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mitem Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Desferal Lbl (Desferal Lbl)

Label for Desferal 500 mg per vial (deferoxamine mesylate) injection powder for solution. The label states use for SC, IM, or IV routes, storage instructions, and manufacturer Novartis Pharma Stein AG, Switzerland, and Wasserburger Arzneimittelwerk GmbH, Germany, with distribution by Novartis Pharmaceuticals Corp. in East Hanover, NJ.*

FDA Label Image

Desferal Pi Usa (Desferal Pi Usa)

Table of contents from the full prescribing information for Desferal (deferoxamine mesylate). It outlines major sections including Indications and Usage, Dosage and Administration, Contraindications, Warnings and Precautions, Adverse Reactions, Drug Interactions, Use in Specific Populations, Overdosage, Description, Clinical Pharmacology, Nonclinical Toxicology, How Supplied/Storage and Handling, and Patient Counseling Information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.